Dr. Bala Reddy is the Founder and Managing Director of Provis Biolabs. With over 25 years of experience in biopharmaceutical development and commercial manufacturing, he has led the development, manufacturing, clinical trials and commercialization of numerous biosimilars, vaccines and human plasma-derived products - including Erythropoietin, Gonadotropin hormones, Darbepoetin, Rituximab, Bevacizumab, Trastuzumab, Adalimumab, Pembrolizumab, Denosumab and Tenecteplase. He has built and scaled biopharmaceutical R&D and manufacturing organizations and has executed global technology in-licensing and out-licensing agreements, product registrations and business operations across international markets. His core expertise spans bioprocess development, protein chemistry, product characterization, and scale-up across microbial and mammalian cell culture platforms.